Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
35.6M
-
Shares change
-
+1.73M
-
Total reported value, excl. options
-
$89.6M
-
Value change
-
+$4.34M
-
Put/Call ratio
-
0.9
-
Number of buys
-
34
-
Number of sells
-
-18
-
Price
-
$2.52
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q3 2017
82 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2017.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.6M shares
of 123M outstanding shares and own 28.89% of the company stock.
Largest 10 shareholders include Broadfin Capital, LLC (6.89M shares), BAKER BROS. ADVISORS LP (5.1M shares), venBio Select Advisor LLC (4.64M shares), BlackRock Inc. (3.72M shares), VANGUARD GROUP INC (3.04M shares), JPMORGAN CHASE & CO (1.51M shares), STATE STREET CORP (944K shares), KENNEDY CAPITAL MANAGEMENT, INC. (901K shares), NORTHERN TRUST CORP (812K shares), and AJO, LP (766K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.